Le Houezec J[au] - Search Results

Year	Number of Results
1984	1
1986	1
1988	1
1989	1
1990	1
1991	1
1993	1
1994	1
1996	1
1998	3
1999	2
2000	1
2002	3
2003	4
2005	3
2006	2
2007	1
2008	1
2009	2
2011	1
2012	2
2013	2
2014	3
2015	3
2016	2
2017	2
2020	1
2022	0

1

[Helping the "hard-core" smokers].

Perriot J, Underner M, Peiffer G, Le Houezec J, Samalin L, Schmitt A, de Chazeron I, Doly-Kuchcik L. Perriot J, et al. Among authors: le houezec j. Rev Mal Respir. 2012 Apr;29(4):448-61. doi: 10.1016/j.rmr.2011.09.048. Epub 2012 Mar 22. Rev Mal Respir. 2012. PMID: 22542404 Review. French.

2

[Tests for evaluating tobacco dependence].

Underner M, Le Houezec J, Perriot J, Peiffer G. Underner M, et al. Among authors: le houezec j. Rev Mal Respir. 2012 Apr;29(4):462-74. doi: 10.1016/j.rmr.2011.09.051. Epub 2012 Mar 23. Rev Mal Respir. 2012. PMID: 22542405 Review. French.

3

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.

Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K. Farsalinos K, et al. Among authors: le houezec j. Toxicol Rep. 2020 Apr 30;7:658-663. doi: 10.1016/j.toxrep.2020.04.012. eCollection 2020. Toxicol Rep. 2020. PMID: 32355638 Free PMC article. No abstract available.

4

Tobacco, nicotine and harm reduction.

Le Houezec J, McNeill A, Britton J. Le Houezec J, et al. Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x. Drug Alcohol Rev. 2011. PMID: 21375611 Review.

5

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

Le Houezec J, Aubin HJ. Le Houezec J, et al. Expert Opin Pharmacother. 2013 Oct;14(14):1959-67. doi: 10.1517/14656566.2013.818978. Epub 2013 Aug 26. Expert Opin Pharmacother. 2013. PMID: 23978314 Review.

6

Nicotine: abused substance and therapeutic agent.

Le Houezec J. Le Houezec J. J Psychiatry Neurosci. 1998 Mar;23(2):95-108. J Psychiatry Neurosci. 1998. PMID: 9549250 Free PMC article. Review.

7

Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes).

Farsalinos KE, Le Houezec J. Farsalinos KE, et al. Among authors: le houezec j. Risk Manag Healthc Policy. 2015 Sep 29;8:157-67. doi: 10.2147/RMHP.S62116. eCollection 2015. Risk Manag Healthc Policy. 2015. PMID: 26457058 Free PMC article. Review.

8

Why a nicotine vaccine?

Le Houezec J. Le Houezec J. Clin Pharmacol Ther. 2005 Nov;78(5):453-5. doi: 10.1016/j.clpt.2005.08.008. Clin Pharmacol Ther. 2005. PMID: 16321611 No abstract available.

9

[What smoking cessation interventions are effective in pregnant women?].

Le Houezec J. Le Houezec J. J Gynecol Obstet Biol Reprod (Paris). 2005 Apr;34 Spec No 1:3S182-93. J Gynecol Obstet Biol Reprod (Paris). 2005. PMID: 15980787 Review. French.

10

Should e-cigarettes be regulated as a medicinal device?

Hajek P, Foulds J, Le Houezec J, Sweanor D, Yach D. Hajek P, et al. Among authors: le houezec j. Lancet Respir Med. 2013 Aug;1(6):429-31. doi: 10.1016/S2213-2600(13)70124-3. Epub 2013 Jul 23. Lancet Respir Med. 2013. PMID: 24429230 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results